Clinical Study
Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
Table 1
Comparison of outcome variables before treatment with adalimumab and at the final visit.
| Variable | Week 0 (baseline) | Month 6 (final visit) | value |
| Anterior chamber inflammation | 2.02 (1.16) | 0.42 (0.62) | <0.001 | Posterior chamber inflammation | 2.38 (2.97) | 0.35 (0.71) | <0.005 | Macular thickness, | 304.54 (125.03) | 230.87 (31.12) | <0.001 | Immunosuppression load | 8.10 (3.99) | 5.08 (3.76) | <0.001 |
|
|
Data as mean (standard deviation).
|